WallStSmart

MetLife Inc (MET)vsPrudential PLC ADR (PUK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MetLife Inc generates 434% more annual revenue ($77.08B vs $14.43B). PUK leads profitability with a 27.6% profit margin vs 4.4%. MET appears more attractively valued with a PEG of 0.60. PUK earns a higher WallStSmart Score of 79/100 (B+).

MET

Buy

63

out of 100

Grade: C+

Growth: 4.7Profit: 4.5Value: 7.3Quality: 5.3
Piotroski: 5/9

PUK

Strong Buy

79

out of 100

Grade: B+

Growth: 7.0Profit: 8.0Value: 10.0Quality: 6.5
Piotroski: 5/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

METSignificantly Overvalued (-146.3%)

Margin of Safety

-146.3%

Fair Value

$32.03

Current Price

$70.39

$38.36 premium

UndervaluedFair: $32.03Overvalued
PUKUndervalued (+77.7%)

Margin of Safety

+77.7%

Fair Value

$143.68

Current Price

$29.67

$114.01 discount

UndervaluedFair: $143.68Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MET5 strengths · Avg: 8.0/10
PEG RatioValuation
0.608/10

Growing faster than its price suggests

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
27.6%8/10

Revenue surging 27.6% year-over-year

Free Cash FlowQuality
$8.09B8/10

Generating 8.1B in free cash flow

PUK6 strengths · Avg: 9.2/10
P/E RatioValuation
9.4x10/10

Attractively priced relative to earnings

Operating MarginProfitability
45.5%10/10

Strong operational efficiency at 45.5%

Return on EquityProfitability
20.6%9/10

Every $100 of equity generates 21 in profit

Profit MarginProfitability
27.6%9/10

Keeps 28 of every $100 in revenue as profit

Debt/EquityHealth
0.299/10

Conservative balance sheet, low leverage

EPS GrowthGrowth
30.8%8/10

Earnings expanding 30.8% YoY

Areas to Watch

MET3 concerns · Avg: 2.7/10
Profit MarginProfitability
4.4%3/10

4.4% margin — thin

Operating MarginProfitability
4.7%3/10

Operating margin of 4.7%

EPS GrowthGrowth
-34.2%2/10

Earnings declined 34.2%

PUK0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : MET

The strongest argument for MET centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 27.6% demonstrates continued momentum. PEG of 0.60 suggests the stock is reasonably priced for its growth.

Bull Case : PUK

The strongest argument for PUK centers on P/E Ratio, Operating Margin, Return on Equity. Profitability is solid with margins at 27.6% and operating margin at 45.5%. Revenue growth of 14.5% demonstrates continued momentum.

Bear Case : MET

The primary concerns for MET are Profit Margin, Operating Margin, EPS Growth. Thin 4.4% margins leave little buffer for downturns.

Bear Case : PUK

No major red flags identified for PUK, but monitor valuation.

Key Dynamics to Monitor

MET profiles as a growth stock while PUK is a mature play — different risk/reward profiles.

PUK carries more volatility with a beta of 0.92 — expect wider price swings.

MET is growing revenue faster at 27.6% — sustainability is the question.

MET generates stronger free cash flow (8.1B), providing more financial flexibility.

Bottom Line

PUK scores higher overall (79/100 vs 63/100), backed by strong 27.6% margins and 14.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MetLife Inc

FINANCIAL SERVICES · INSURANCE - LIFE · USA

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with 90 million customers in over 60 countries.

Prudential PLC ADR

FINANCIAL SERVICES · INSURANCE - LIFE · USA

Prudential plc offers life and health insurance, retirement and asset management solutions to people in Asia, the United States and Africa. The company is headquartered in London, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?